FERD3L and breast carcinoma: Accordingly, by means of a biological pathway analysis of these genes using the publicly available resource Pathway Commons [24], we observed that FERD3L and TRIP10 are able to interact with several genes (Additional file 5: Figure S1) which have been previously associated with therapy resistance of breast cancer and other types of tumors [23, 25].